APA (7th ed.) Citation

K, R., S, F., E, G., K, C., M, G., & G, A. (2021). Anaplastic Lymphoma Kinase Inhibitor in Treatment of Inflammatory Myofibroblastic Tumor of the Tongue in Infancy. Journal of pediatric hematology/oncology, 43(4), e521. https://doi.org/10.1097/MPH.0000000000001907

Chicago Style (17th ed.) Citation

K, Rao, Farooki S, Guest E, Chastain K, Gener M, and Akangire G. "Anaplastic Lymphoma Kinase Inhibitor in Treatment of Inflammatory Myofibroblastic Tumor of the Tongue in Infancy." Journal of Pediatric Hematology/oncology 43, no. 4 (2021): e521. https://doi.org/10.1097/MPH.0000000000001907.

MLA (9th ed.) Citation

K, Rao, et al. "Anaplastic Lymphoma Kinase Inhibitor in Treatment of Inflammatory Myofibroblastic Tumor of the Tongue in Infancy." Journal of Pediatric Hematology/oncology, vol. 43, no. 4, 2021, p. e521, https://doi.org/10.1097/MPH.0000000000001907.